Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop ...

Atara Biotherapeutics (ATRA) came out with a quarterly loss of $2.93 per share ... estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based ...

Yatra Online, Inc. (YTRA) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to loss of $0.02 per share a year ago. These figures ...

THOUSAND OAKS, Calif. (AP) — THOUSAND OAKS, Calif. (AP) — Atara Biotherapeutics Inc. (ATRA) on Tuesday reported a loss of $21.9 million in its third quarter. On a per-share basis, the Thousand Oaks, ...

Analysts are estimating that Atara Biotherapeutics will report an earnings per share (EPS) of $-1.93. Atara Biotherapeutics ...

How to use Atara Biotherapeutics Inc. ATRA as a Forecasting Tool ...

Stock prices used were the afternoon prices of Oct. 25, 2024. The video was published on Oct. 27, 2024. Ever feel like you missed the boat in buying the most successful stocks? Then you’ll want ...

Trump Media stock is surging as more investors are betting that Donald Trump will win the presidential election. Trump Media's valuation is benefiting from meme-stock momentum. The stock will ...

Buy ATRA near 7.84 target 12.82 stop loss @ 7.82 Details The technical summary data tells us to buy ATRA near 7.84 with an upside target of 12.82. This data also tells us to set a stop loss @ 7.82 to ...

India has 29 states with at least 720 districts comprising of approximately 6 lakh villages, and over 8200 cities and towns. Indian postal department has allotted a unique postal code of pin code ...

The stock’s current closing high is $138.07, hit on Monday, but Nvidia ended at $136.93 on Thursday. Emily Bary is a MarketWatch news editor based in New York.